Palogic Value Management L.P. Boosts Stock Position in Health Catalyst, Inc. $HCAT

Key Points

• Palogic Value Management L.P. has significantly increased its stake in Health Catalyst, Inc. by 111.5% in the first quarter, now owning 676,900 shares valued at approximately $3.06 million.
• Other institutional investors, including State of Wyoming and Hsbc Holdings PLC, have also boosted their positions in Health Catalyst, leading to 85% of the company's stock being held by institutional investors.
• Analysts have mixed ratings for Health Catalyst, with a current consensus rating of "Hold" and an average price target of $5.42, indicating a cautious outlook on the stock's performance.

Palogic Value Management L.P. increased its holdings in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 111.5% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 676,900 shares of the company's stock after purchasing an additional 356,900 shares during the period. Health Catalyst accounts for 1.3% of Palogic Value Management L.P.'s holdings, making the stock its 22nd biggest holding. Palogic Value Management L.P. owned 0.96% of Health Catalyst worth $3,066,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Group One Trading LLC increased its stake in Health Catalyst by 107.6% in the 4th quarter. Group One Trading LLC now owns 4,360 shares of the company's stock worth $31,000 after acquiring an additional 2,260 shares during the last quarter. XTX Topco Ltd purchased a new stake in shares of Health Catalyst in the 1st quarter worth $54,000. Aquatic Capital Management LLC purchased a new stake in shares of Health Catalyst in the 4th quarter worth $63,000. Brevan Howard Capital Management LP bought a new stake in Health Catalyst during the fourth quarter valued at about $92,000. Finally, MCF Advisors LLC bought a new stake in Health Catalyst during the first quarter valued at about $113,000. 85.00% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on HCAT shares. Wells Fargo & Company dropped their price objective on Health Catalyst from $10.00 to $6.00 and set an "overweight" rating on the stock in a research report on Monday, August 11th. Canaccord Genuity Group decreased their price target on Health Catalyst from $9.00 to $5.00 and set a "buy" rating for the company in a research note on Friday, August 29th. Piper Sandler cut Health Catalyst from an "overweight" rating to a "neutral" rating and decreased their price target for the company from $8.00 to $4.00 in a research note on Wednesday, August 27th. Stifel Nicolaus decreased their price target on Health Catalyst from $5.50 to $4.50 and set a "hold" rating for the company in a research note on Friday, August 8th. Finally, Evercore ISI increased their price target on Health Catalyst from $3.00 to $4.00 and gave the company an "in-line" rating in a research note on Thursday, August 28th. Three equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to MarketBeat, Health Catalyst presently has an average rating of "Hold" and an average target price of $4.73.

Health Catalyst Price Performance

Shares of Health Catalyst stock traded up $0.00 on Thursday, reaching $3.24. The company's stock had a trading volume of 365,842 shares, compared to its average volume of 727,265. The company has a market capitalization of $228.08 million, a P/E ratio of -2.14 and a beta of 1.53. Health Catalyst, Inc. has a 52-week low of $2.52 and a 52-week high of $9.24. The stock has a 50-day moving average price of $3.60 and a 200-day moving average price of $3.97. The company has a quick ratio of 1.83, a current ratio of 1.83 and a debt-to-equity ratio of 0.44.

Health Catalyst Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.